Cornerstone Capital Management Holdings LLC. raised its position in shares of Lantheus Holdings Inc (NASDAQ:LNTH) by 65.1% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 95,600 shares of the medical equipment provider’s stock after purchasing an additional 37,700 shares during the period. Cornerstone Capital Management Holdings LLC. owned about 0.25% of Lantheus worth $1,701,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in LNTH. California State Teachers Retirement System grew its stake in Lantheus by 5.2% during the 3rd quarter. California State Teachers Retirement System now owns 48,609 shares of the medical equipment provider’s stock valued at $865,000 after purchasing an additional 2,409 shares during the last quarter. Rhumbline Advisers grew its stake in Lantheus by 5.0% during the 3rd quarter. Rhumbline Advisers now owns 53,702 shares of the medical equipment provider’s stock valued at $956,000 after purchasing an additional 2,560 shares during the last quarter. New York State Teachers Retirement System grew its stake in Lantheus by 13.4% during the 3rd quarter. New York State Teachers Retirement System now owns 23,713 shares of the medical equipment provider’s stock valued at $422,000 after purchasing an additional 2,800 shares during the last quarter. LS Investment Advisors LLC grew its stake in Lantheus by 47.1% during the 3rd quarter. LS Investment Advisors LLC now owns 9,306 shares of the medical equipment provider’s stock valued at $166,000 after purchasing an additional 2,981 shares during the last quarter. Finally, First Trust Advisors LP boosted its stake in shares of Lantheus by 24.8% in the second quarter. First Trust Advisors LP now owns 23,468 shares of the medical equipment provider’s stock worth $414,000 after buying an additional 4,669 shares during the last quarter. 91.91% of the stock is owned by hedge funds and other institutional investors.
In related news, insider Michael P. Duffy sold 11,917 shares of Lantheus stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $21.63, for a total value of $257,764.71. Following the completion of the transaction, the insider now directly owns 152,301 shares in the company, valued at $3,294,270.63. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Michael P. Duffy sold 21,655 shares of Lantheus stock in a transaction on Wednesday, January 10th. The shares were sold at an average price of $22.40, for a total value of $485,072.00. Following the completion of the transaction, the insider now owns 156,784 shares of the company’s stock, valued at $3,511,961.60. The disclosure for this sale can be found here. Insiders sold 44,886 shares of company stock valued at $986,201 over the last quarter. 2.30% of the stock is currently owned by company insiders.
Lantheus Holdings Inc (LNTH) traded down $0.17 during trading hours on Friday, hitting $23.48. The company had a trading volume of 214,257 shares, compared to its average volume of 342,251. Lantheus Holdings Inc has a 12-month low of $7.95 and a 12-month high of $24.10. The company has a debt-to-equity ratio of -3.41, a quick ratio of 2.46 and a current ratio of 2.96. The firm has a market capitalization of $880.45 and a PE ratio of 29.35.
Lantheus (NASDAQ:LNTH) last posted its quarterly earnings results on Thursday, November 2nd. The medical equipment provider reported $0.24 EPS for the quarter, beating the consensus estimate of $0.20 by $0.04. The firm had revenue of $79.94 million during the quarter, compared to analysts’ expectations of $77.18 million. Lantheus had a negative return on equity of 46.45% and a net margin of 9.59%. The business’s revenue for the quarter was up 9.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.15 earnings per share. sell-side analysts forecast that Lantheus Holdings Inc will post 1.05 EPS for the current year.
A number of analysts have recently commented on LNTH shares. Credit Suisse Group upped their target price on Lantheus from $19.00 to $23.00 and gave the stock a “neutral” rating in a research note on Friday, November 3rd. Jefferies Group reiterated a “buy” rating and set a $22.00 price target on shares of Lantheus in a research report on Thursday, October 12th. Zacks Investment Research upgraded Lantheus from a “hold” rating to a “strong-buy” rating and set a $26.00 price target on the stock in a research report on Tuesday, November 7th. Wells Fargo & Co upgraded Lantheus from a “market perform” rating to an “outperform” rating in a research report on Thursday, November 2nd. Finally, BidaskClub downgraded Lantheus from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, December 5th. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. Lantheus presently has a consensus rating of “Buy” and an average price target of $24.50.
ILLEGAL ACTIVITY NOTICE: “Lantheus Holdings Inc (LNTH) Shares Bought by Cornerstone Capital Management Holdings LLC.” was reported by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this piece can be viewed at https://www.thelincolnianonline.com/2018/01/13/lantheus-holdings-inc-lnth-shares-bought-by-cornerstone-capital-management-holdings-llc-updated-updated.html.
Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.
Receive News & Ratings for Lantheus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus and related companies with MarketBeat.com's FREE daily email newsletter.